ClinConnect ClinConnect Logo
Search / Trial NCT06961552

The Effect of Reflexology on Premenstrual Syndrome Symptoms, Pain and Quality of Life

Launched by SAGLIK BILIMLERI UNIVERSITESI · May 5, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Reflexology Premenstrual Syndrome Pms Pain Quality Of Life

ClinConnect Summary

This clinical trial is studying the effects of reflexology, a type of massage that focuses on specific points on the feet, on symptoms of premenstrual syndrome (PMS), pain, and overall quality of life in women. The researchers want to see if reflexology can help relieve the discomfort that many women experience before their menstrual period. The study will take place from January to December 2025 and will involve 70 women who experience PMS symptoms.

To participate, women need to be at least 18 years old, have regular menstrual cycles, and score above a certain level on a PMS scale. Participants will receive reflexology sessions for eight weeks, starting just after their period ends, with specific techniques applied to their feet over a total of 30 minutes each week. Those in the control group will not receive any treatment. It's important to note that women with certain health issues or those who are pregnant will not be eligible for the study. This trial could provide valuable insights into how reflexology might help improve the lives of women struggling with PMS.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria Women who are 18 years of age or older, No communication problems, Scoring 111 and above on the Premenstrual Syndrome Scale, Having regular menstruation for the last six months, Having a menstrual cycle of 22-35 days, Having a menstrual period of no longer than 7 days, Not receiving medical or surgical treatment for PMS, Having no other gynecological problems, Having no psychiatric problems, Women who have no chronic illness in the last three months and have not undergone any gynecological surgery
  • Exclusion Criteria Women who score 110 or less on the Premenstrual Syndrome Scale, Women who are pregnant, Women who use hormonal contraception (such as oral contraceptives and injections), Women who have another gynecological problem, Women who have psychiatric problems, Women who have ulcers, varicose veins, thrombus, phlebitis, ecchymosis, hematoma, infection on both feet, women with impaired skin integrity, and women who have a history of foot surgery will not be included in the study.

About Saglik Bilimleri Universitesi

Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.

Locations

Patients applied

0 patients applied

Trial Officials

melike dişsiz, PhD

Study Director

Saglik Bilimleri Universitesi

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported